Entrada Therapeutics Inc (TRDA)
14.34
+0.29
(+2.06%)
USD |
NASDAQ |
May 09, 16:00
14.34
0.00 (0.00%)
After-Hours: 17:19
Entrada Therapeutics Price: 14.34 for May 9, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 08, 2024 | 13.52 | 14.24 | 13.49 | 14.05 | 57449.00 |
May 07, 2024 | 13.79 | 14.11 | 13.36 | 13.88 | 44564.00 |
May 06, 2024 | 13.42 | 13.82 | 13.26 | 13.50 | 25808.00 |
May 03, 2024 | 13.70 | 13.84 | 12.92 | 13.16 | 38162.00 |
May 02, 2024 | 13.25 | 13.59 | 12.72 | 13.56 | 67224.00 |
May 01, 2024 | 11.98 | 13.36 | 11.98 | 13.25 | 99275.00 |
Apr 30, 2024 | 12.29 | 12.39 | 11.82 | 11.85 | 68824.00 |
Apr 29, 2024 | 12.33 | 12.55 | 12.06 | 12.34 | 52697.00 |
Apr 26, 2024 | 12.10 | 12.73 | 12.10 | 12.45 | 25818.00 |
Apr 25, 2024 | 12.23 | 12.58 | 11.91 | 12.36 | 84124.00 |
Apr 24, 2024 | 12.79 | 12.79 | 12.31 | 12.43 | 38559.00 |
Apr 23, 2024 | 13.08 | 14.03 | 12.78 | 12.89 | 43975.00 |
Apr 22, 2024 | 12.24 | 13.13 | 12.20 | 13.10 | 119085.0 |
Apr 19, 2024 | 11.83 | 12.19 | 11.81 | 12.15 | 87455.00 |
Apr 18, 2024 | 12.12 | 12.40 | 11.82 | 11.91 | 130286.0 |
Apr 17, 2024 | 12.71 | 12.89 | 12.16 | 12.22 | 56429.00 |
Apr 16, 2024 | 12.87 | 13.00 | 12.52 | 12.72 | 49596.00 |
Apr 15, 2024 | 13.03 | 13.54 | 12.69 | 12.89 | 108935.0 |
Apr 12, 2024 | 13.18 | 13.51 | 12.76 | 12.95 | 55707.00 |
Apr 11, 2024 | 12.75 | 13.29 | 12.18 | 13.26 | 92942.00 |
Apr 10, 2024 | 12.92 | 13.32 | 12.23 | 12.52 | 181822.0 |
Apr 09, 2024 | 13.58 | 13.66 | 13.00 | 13.28 | 69240.00 |
Apr 08, 2024 | 13.89 | 14.13 | 13.39 | 13.45 | 56882.00 |
Apr 05, 2024 | 13.83 | 14.06 | 13.52 | 13.81 | 104020.0 |
Apr 04, 2024 | 14.08 | 14.34 | 13.68 | 13.83 | 52003.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
5.49
Minimum
May 09 2022
35.00
Maximum
Nov 17 2021
14.12
Average
13.97
Median
Apr 05 2023
Price Benchmarks
GlycoMimetics Inc | 0.2994 |
Lyell Immunopharma Inc | 2.68 |
Candel Therapeutics Inc | 9.93 |
Eliem Therapeutics Inc | 8.955 |
NovaBay Pharmaceuticals Inc | 0.0864 |
Price Related Metrics
PE Ratio | 22.76 |
PS Ratio | 2.996 |
Price to Book Value | 1.797 |
Earnings Yield | 4.39% |
Market Cap | 484.10M |
Operating PE Ratio | 20.56 |
Normalized PE Ratio | 22.76 |